Login to Your Account

Avalanche downs Annapurna to bulk up in gene therapy

By Marie Powers
News Editor

Monday, February 1, 2016

Avalanche Biotechnologies Inc. plans to acquire privately held Annapurna Therapeutics SAS through an all-stock transaction that will combine pipelines, management teams and resources with the goal of creating a gene therapy company that’s bigger than the sum of its parts. 

To continue reading subscribe now to Latest News

Learn More about Latest News

Already a subscriber? Sign In or Buy now to activate your subscription